Abbott expended its manufacturing capacity with the launch of a new facility in Kilkenny, Ireland, to produce sensors for ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Robert B. Ford is Abbott's Chairman of the Board and Chief Executive Officer. He assumed the role of Chairman in December 2021, having been appointed President and Chief Executive Officer in March ...

A group of Abbott HeartMates gathered in Buffalo to meet Damar Hamlin and build community around heart health during the ...

The AMPLATZER Piccolo™ Occluder is a percutaneous, transcatheter occlusion device intended for the nonsurgical closure of a patent ductus arteriosus (PDA). Pregnancy — Minimize radiation exposure to ...

What foods spike glucose? You might be surprised. Even foods widely considered to be healthy can impact your glucose levels, and that’s where continuous glucose monitoring (CGM) can help.

To protect the devices, products, and systems that connect patients to healthcare professionals and institutions, we take a broad and deep approach to ensuring safety and security. Our cybersecurity ...

We're nearing the end of the competition: football season and “The We Give Blood Drive.” This means you only have a few shots left at beating your rival Big Ten school in the conference-wide race to ...

In 1888, physician and drug store proprietor Dr. Wallace C. Abbott began producing accurate, scientifically formulated medications with the goal of providing more effective therapies to patients and ...

People participate in clinical trials for a variety of reasons. Some of these reasons include the desire to help others, learn more about their conditions, receive the latest care from trained staff, ...

We view philanthropy as a powerful source for driving social innovations that lead to more resilient, healthier communities. It provides an opportunity for us to pioneer new ideas, generate new ...

When COVID-19 shut down the world's economy and activity, we got busy ramping up capabilities to offer the world the testing it needed to track infections and get people back to doing the things they ...